{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:06:06Z","timestamp":1790802366794,"version":"4.1.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejca.2026.117049","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:47:55Z","timestamp":1789195675000},"page":"117049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genomic landscape of sweat gland carcinomas: Clinical applications and future directions"],"prefix":"10.1016","volume":"247","author":[{"given":"Lara","family":"Racz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-8569","authenticated-orcid":false,"given":"Almut","family":"B\u00f6er-Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedegund","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Ugurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-653X","authenticated-orcid":false,"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-252X","authenticated-orcid":false,"given":"Silke","family":"Redler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.117049_bib1","doi-asserted-by":"crossref","unstructured":"Ziemer M., Erdmann M., Agaimy A., Becker J.C., B\u00f6er-Auer A., Helbig D., et al. S1 guideline sweat gland carcinoma. JDDG: Journal Der Deutschen Dermatologischen Gesellschaft n.d.;n\/a. https:\/\/doi.org\/10.1111\/ddg.70107x.","DOI":"10.1111\/ddg.70107x"},{"key":"10.1016\/j.ejca.2026.117049_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archdermatol.2010.105","article-title":"Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study","volume":"146","author":"Blake","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00292-014-1929-8","article-title":"Cutaneous adnexal and salivary gland tumours. Similarities and differences","volume":"35","author":"Ihrler","year":"2014","journal-title":"Pathologe"},{"key":"10.1016\/j.ejca.2026.117049_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjd.17321","article-title":"The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study","volume":"180","author":"De Giorgi","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/PAS.0b013e3181966762","article-title":"Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome","volume":"33","author":"Kazakov","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/bjd.20604","article-title":"High tumour mutational burden and EGFR\/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma","volume":"185","author":"Westphal","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41417-021-00347-z","article-title":"Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies","volume":"29","author":"Denisova","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.ejca.2026.117049_bib8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jaad.2023.11.057","article-title":"Mutational landscape of advanced extramammary Paget disease with comprehensive genomic profiling tests: A cohort study in a Japanese real-world setting","volume":"90","author":"Iwasawa","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"25","key":"10.1016\/j.ejca.2026.117049_bib9","first-page":"00137","article-title":"Prevalence of FOXA1 and ERBB2 activating mutations in extramammary Paget\u2019s disease: A retrospective multicenter analysis of 99 cases from Japanese and Taiwanese cohorts","volume":"S0923-1811","author":"Omi","year":"2025","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ejca.2026.117049_bib10","article-title":"Personalized medicine: An alternative for cancer treatment","volume":"42","author":"Singh","year":"2024","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.ejca.2026.117049_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/cancers14030476","article-title":"Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors","volume":"14","author":"Macagno","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2026.117049_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-025-03586-7","article-title":"Whole-exome sequencing identifies distinct genomic aberrations in eccrine porocarcinomas and poromas","volume":"20","author":"Puttonen","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ejca.2026.117049_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2024.06.006","article-title":"Ancillary immunohistochemical and molecular testing in the classification of cutaneous sweat gland\/duct neoplasms: A validation study with emphasis on histomorphologic correlation and pathological diagnosis","volume":"150","author":"Nguyen","year":"2024","journal-title":"Human Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/PAS.0000000000001693","article-title":"NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms","volume":"45","author":"Macagno","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/his.15479","article-title":"Methylation analysis as a diagnostic tool for sweat gland tumours classification with emphasis on the distinction between digital papillary adenocarcinoma and mimickers","volume":"87","author":"Sohier","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.117049_bib16","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1172\/JCI126185","article-title":"Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma","volume":"129","author":"Sekine","year":"2019","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ejca.2026.117049_bib17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/PAS.0000000000001261","article-title":"Secretory Carcinoma of the Skin: Report of 6 Cases, Including a Case With a Novel NFIX-PKN1 Translocation","volume":"43","author":"Kastnerova","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PAS.0000000000000734","article-title":"Secretory Carcinoma of the Skin Harboring ETV6 Gene Fusions: A Cutaneous Analogue to Secretory Carcinomas of the Breast and Salivary Glands","volume":"41","author":"Bishop","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/cup.14408","article-title":"Microsecretory adenocarcinoma of the skin, a novel type of sweat gland carcinoma: Report of three additional cases","volume":"50","author":"Bogiatzi","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/his.15214","article-title":"Porocarcinomas with PAK1\/2\/3 fusions: a series of 12 cases","volume":"85","author":"Kervarrec","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.117049_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/cup.14782","article-title":"Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes","author":"Bayraktar","year":"2025","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib22","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1111\/1346-8138.13830","article-title":"Translocation of the MAML2 gene in hidradenocarcinoma","volume":"44","author":"Yoshimi","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21873\/cgp.20184","article-title":"NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma","volume":"17","author":"Panagopoulos","year":"2020","journal-title":"Cancer Genom Proteom"},{"key":"10.1016\/j.ejca.2026.117049_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5858\/arpa.2022-0474-OA","article-title":"Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations","volume":"148","author":"Cornejo","year":"2023","journal-title":"Arch Pathol & Lab Med"},{"key":"10.1016\/j.ejca.2026.117049_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100592","article-title":"Squamoid Eccrine Ductal Carcinoma Displays Ultraviolet Mutations and Intermediate Gene Expression Relative to Squamous Cell Carcinoma, Microcystic Adnexal Carcinoma, and Porocarcinoma","volume":"37","author":"Harms","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib26","article-title":"Exploring the driver events of eccrine poromas and porocarcinomas: A retrospective, cross-institutional study of 54 cases","author":"Arends","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pathol.2017.10.011","article-title":"Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas","volume":"50","author":"Bosic","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.ejca.2026.117049_bib28","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41467-019-09979-0","article-title":"ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma","volume":"10","author":"Rashid","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.117049_bib29","doi-asserted-by":"crossref","first-page":"22146","DOI":"10.2340\/actadv.v104.22146","article-title":"Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis","volume":"104","author":"LIN","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2026.117049_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100229","article-title":"Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics","volume":"3","author":"Nishimura","year":"2023","journal-title":"JID Innov"},{"key":"10.1016\/j.ejca.2026.117049_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jid.2018.08.030","article-title":"Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget\u2019s Diseases","volume":"139","author":"Zhang","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/1346-8138.16343","article-title":"Intertumor and intratumor heterogeneity of PIK3CA mutations in extramammary Paget\u2019s disease","volume":"49","author":"Kusaba","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib33","first-page":"1115","article-title":"Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesions","volume":"22","author":"Holst","year":"2024","journal-title":"JDDG J Der Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2026.117049_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.humpath.2015.12.015","article-title":"Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations","volume":"51","author":"Harms","year":"2016","journal-title":"Human Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib35","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/modpathol.2011.48","article-title":"A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas","volume":"24","author":"Dias-Santagata","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047290","article-title":"Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses","volume":"7","author":"Le","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2026.117049_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007088","article-title":"Systematic discovery of the functional impact of somatic genome alterations in individual tumors through tumor-specific causal inference","volume":"15","author":"Cai","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.ejca.2026.117049_bib38","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/cup.14008","article-title":"Poroid adnexal skin tumors with fusions exhibit similar histopathologic features: A series of six -rearranged adnexal skin tumors","volume":"48","author":"Prieto-Granada","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib39","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/PAS.0000000000002098","article-title":"Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey","volume":"47","author":"Kervarrec","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib40","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cup.14265","article-title":"Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions","volume":"49","author":"Snow","year":"2022","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/cup.14575","article-title":"Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion","volume":"51","author":"Li","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib42","first-page":"9","article-title":"YAP\/TAZ as master regulators in cancer \u2013 modulation, function and therapeutic approaches","volume":"4","author":"Piccolo","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ejca.2026.117049_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jdcr.2024.01.038","article-title":"Metastatic porocarcinoma: A case demonstrating objective response to pembrolizumab","volume":"50","author":"Benhayoun","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.ejca.2026.117049_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.70015","article-title":"Successful Treatment of Metastatic Eccrine Porocarcinoma With Nivolumab","author":"Nishio","year":"2025","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2021.01.012","article-title":"Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab","volume":"146","author":"Comito","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.117049_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/bjd\/ljaf303","article-title":"Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial","volume":"193","author":"Becker","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib47","doi-asserted-by":"crossref","first-page":"a006308","DOI":"10.1101\/mcs.a006308","article-title":"Pazopanib elicits remarkable response in metastatic porocarcinoma: a functional precision medicine approach","volume":"9","author":"Chan","year":"2023","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.ejca.2026.117049_bib48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/cup.14491","article-title":"Primary mucoepidermoid carcinoma of the external auditory canal with a CRTC1::MAML2 fusion: A case report and a review of literature","volume":"50","author":"De la Sancha","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib49","doi-asserted-by":"crossref","first-page":"adv22146","DOI":"10.2340\/actadv.v104.22146","article-title":"Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis","volume":"104","author":"Lin","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2026.117049_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2022.08.004","article-title":"Clinicopathological and genomic copy number variation analysis in nodular hidradenoma and hidradenocarcinoma with focus on prognostically important features","volume":"129","author":"Jiang","year":"2022","journal-title":"Human Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/DAD.0000000000002933","article-title":"Gene Fusion-Driven Cutaneous Adnexal Neoplasms: An Updated Review Emphasizing Molecular Characteristics","volume":"47","author":"Cazzato","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/modpathol.2015.48","article-title":"Morphologically low-grade spiradenocarcinoma: a clinicopathologic study of 19 cases with emphasis on outcome and MYB expression","volume":"28","author":"van der Horst","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1399-0004.2006.00667.x","article-title":"CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes","volume":"70","author":"Young","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejca.2026.117049_bib54","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/DAD.0000000000002984","article-title":"Architecturally Low-Grade Pure Cylindrocarcinoma With CYLD1 Mutation","volume":"47","author":"Knittel","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/ced\/llaf064","article-title":"Metastatic malignant cylindroma arising on a background of digenic inheritance of BRCA2 and CYLD pathogenic variants targeted with PARP inhibition","volume":"50","author":"Fostier","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib56","series-title":"A rare case of metastatic spiradenocarcinoma with CDKN2A mutation","first-page":"230","author":"Trinh","year":"2024"},{"issue":"5","key":"10.1016\/j.ejca.2026.117049_bib57","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/PO.20.00285","article-title":"Response to PD-1 Immunotherapy in Metastatic spiradenocarcinoma","author":"Wu","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ejca.2026.117049_bib58","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature01802","article-title":"The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination","volume":"424","author":"Kovalenko","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2026.117049_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cup.14539","article-title":"Apocrine carcinoma with marked sebocyte-like cytological features: A report of two cases","volume":"51","author":"Sasaki-Saito","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib60","article-title":"Favorable response to combined androgen blockade for metastatic cutaneous apocrine carcinoma: a case report","volume":"5","author":"Imajima","year":"2020","journal-title":"IJS Oncol"},{"key":"10.1016\/j.ejca.2026.117049_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cup.14607","article-title":"Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion","volume":"51","author":"Lenskaya","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib62","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00428-011-1149-z","article-title":"PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study","volume":"459","author":"Matsuyama","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejca.2026.117049_bib63","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/cup.13965","article-title":"An atypical chondroid syringoma with malignant degeneration: Utility of comparative genomic hybridization in confirming the diagnosis","volume":"48","author":"Zia","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.21873\/cgp.20139","article-title":"Fusion of the Genes PHF1 and TFE3 in Malignant Chondroid Syringoma","volume":"16","author":"Panagopoulos","year":"2019","journal-title":"Cancer Genom Proteom"},{"key":"10.1016\/j.ejca.2026.117049_bib65","doi-asserted-by":"crossref","first-page":"e1420","DOI":"10.1111\/jdv.19346","article-title":"Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature","volume":"37","author":"Dupont","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2026.117049_bib66","article-title":"Metastatic Syringocystadenocarcinoma Papilliferum: A Case Report, Tumor Genomic Profiling, and Literature Review","volume":"2020","author":"Altunel","year":"2020","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.ejca.2026.117049_bib67","article-title":"Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature","volume":"2022","author":"Halsey","year":"2022","journal-title":"Case Rep Dermatol Med"},{"key":"10.1016\/j.ejca.2026.117049_bib68","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/DSS.0000000000001403","article-title":"Syringocystadenoma Papilliferum in Coexistence With Verrucous Carcinoma on the Face","volume":"44","author":"Park","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2026.117049_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cup.13572","article-title":"Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases","volume":"47","author":"Alegr\u00eda-Landa","year":"2020","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.humpath.2023.10.004","article-title":"Panviral metagenomic sequencing provides further evidence for human papillomavirus 42 association with digital papillary adenocarcinoma","volume":"143","author":"Tekin","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib71","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jmoldx.2022.01.011","article-title":"Defining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor\/Normal Matched Sequencing Data","volume":"24","author":"Vanderbilt","year":"2022","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ejca.2026.117049_bib72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/DAD.0000000000001694","article-title":"A Case Report of Papillary Digital Adenocarcinoma With BRAFV600E Mutation and Quantified Mutational Burden","volume":"43","author":"Trager","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib73","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/2159-8290.CD-22-0489","article-title":"Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers","volume":"13","author":"Leiendecker","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejca.2026.117049_bib74","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cup.14386","article-title":"Two distinct pathogenic pathways of digital papillary adenocarcinoma - BRAF mutation or low-risk HPV infection","volume":"50","author":"Bui","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib75","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anndiagpath.2015.08.002","article-title":"Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma","volume":"19","author":"Bell","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib76","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bjd.17446","article-title":"Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma","volume":"180","author":"Surowy","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib77","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/his.15479","article-title":"Methylation analysis as a diagnostic tool for sweat gland tumours classification with emphasis on the distinction between digital papillary adenocarcinoma and mimickers","volume":"87","author":"Sohier","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.117049_bib78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12957-022-02601-6","article-title":"Four calcium signaling pathway-related genes were upregulated in microcystic adnexal carcinoma: transcriptome analysis and immunohistochemical validation","volume":"20","author":"Yu","year":"2022","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejca.2026.117049_bib79","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41379-019-0424-4","article-title":"Next-generation sequencing implicates oncogenic roles for p53 and JAK\/STAT signaling in microcystic adnexal carcinomas","volume":"33","author":"Chan","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib80","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/DAD.0000000000002456","article-title":"Whole-Exome Sequencing of a Case of Squamoid Eccrine Ductal Carcinoma Reveal Similarities With Cutaneous Squamous Cell Carcinoma","volume":"45","author":"Grube","year":"2023","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib81","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/cancers15051390","article-title":"Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACC","volume":"15","author":"Brayer","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2026.117049_bib82","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/his.14565","article-title":"Primary cutaneous adenoid cystic carcinoma: a clinicopathologic, immunohistochemical, and fluorescence in-situ hybridisation study of 13 cases","volume":"80","author":"Lv","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.117049_bib83","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/DAD.0000000000001294","article-title":"Lack of Deletion of 1p36 in 8 Cases of Primary Adenoid Cystic Carcinoma of the Skin","volume":"41","author":"Kyrpychova","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib84","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/DAD.0000000000001091","article-title":"Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts","volume":"40","author":"Kyrpychova","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib85","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/PAS.0000000000001261","article-title":"Secretory Carcinoma of the Skin: Report of 6 Cases, Including a Case With a Novel NFIX-PKN1 Translocation","volume":"43","author":"Kastnerova","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib86","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/cup.14028","article-title":"Secretory carcinoma of the skin with lymph node metastases and recurrence in both lungs: A case report","volume":"48","author":"Taniguchi","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib87","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/DAD.0000000000000566","article-title":"Secretory\u201d Carcinoma of the Skin Mimicking Secretory Carcinoma of the Breast: Case Report and Literature Review","volume":"38","author":"Huang","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib88","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1111\/1346-8138.17218","article-title":"Marked effect of larotrectinib on primary cutaneous secretory carcinoma: A case report","volume":"51","author":"Hayakawa","year":"2024","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib89","volume":"6","author":"Delgado","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2026.117049_bib90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/DAD.0000000000002788","article-title":"Cutaneous \u201cMicrocystic\u201d Microsecretory Adenocarcinoma With Marked Adnexal Hyperplasia: A Simulant of Microcystic Adnexal Carcinoma","volume":"47","author":"Novice","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib91","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cup.14277","article-title":"Microsecretory adenocarcinoma of the external ear canal","volume":"50","author":"Dibbern","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib92","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cup.14271","article-title":"Microsecretory adenocarcinoma of the skin harboring recurrent SS18 fusions: A cutaneous analog to a newly described salivary gland tumor","volume":"50","author":"Bishop","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100889","article-title":"Comprehensive Molecular Profiling of Cribriform Tumors: Identification of Recurrent 6q\/9q Codeletion and CD38 Expression","volume":"38","author":"Sohier","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100916","article-title":"Cribriform Tumor of the Skin: Identification of 6q and 9q Loss as a Recurrent Cytogenomic Alteration","volume":"39","author":"Ronen","year":"2026","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib95","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/DAD.0000000000002495","article-title":"Signet-Ring Cell\/Histiocytoid Carcinoma: Report of Two Cases and Systematic Review of the Literature on the Epidemiology, Clinical Characteristics, and Pathological and Molecular Findings","volume":"45","author":"Michalek","year":"2023","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib96","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/his.14436","article-title":"Signet-ring cell\/histiocytoid carcinoma of the axilla: a clinicopathological and genetic analysis of 11 cases, review of the literature, and comparison with potentially related tumours","volume":"79","author":"Goto","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.117049_bib97","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cup.13838","article-title":"Signet-ring cell\/histiocytoid carcinoma in the axilla: A case report with genetic analysis using next-generation sequencing","volume":"48","author":"Ito","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib98","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.15444","article-title":"Primary cutaneous NUT adnexal carcinoma: morphologic, genetic and methylation analysis of seven new cases with comparison to extracutaneous NUT carcinoma and NUTM1-rearranged porocarcinoma","volume":"87","author":"Legrand","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.117049_bib99","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/DAD.0000000000003034","article-title":"Primary Cutaneous NUT Adnexal Carcinoma With BRD4::NUTM1 Fusion: A 19-Year Follow-Up","volume":"47","author":"Ibrahim","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cup.14602","article-title":"Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion","volume":"51","author":"Shah","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib101","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1158\/0008-5472.CAN-23-2545","article-title":"The BRD4\u2013NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma","volume":"83","author":"Durall","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2026.117049_bib102","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/PAS.0000000000002240","article-title":"Primary Cutaneous NUT Carcinoma: Clinicopathologic and Genetic Study of 4 Cases","volume":"48","author":"Goto","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.860830","article-title":"NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics","volume":"12","author":"Moreno","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2026.117049_bib104","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.15444","article-title":"Primary cutaneous NUT adnexal carcinoma: morphologic, genetic and methylation analysis of seven new cases with comparison to extracutaneous NUT carcinoma and NUTM1-rearranged porocarcinoma","volume":"87","author":"Legrand","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.117049_bib105","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/1346-8138.15515","article-title":"Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget\u2019s disease: Four cases and a review","volume":"47","author":"Sekiguchi","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib106","first-page":"2677","article-title":"Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget\u2019s disease","volume":"17","author":"Lu","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejca.2026.117049_bib107","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12032-018-1154-z","article-title":"Assessment of the methods used to detect HER2-positive advanced extramammary Paget\u2019s disease","volume":"35","author":"Hirai","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejca.2026.117049_bib108","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/bjd.12249","article-title":"Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease","volume":"168","author":"Tanaka","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib109","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/DAD.0b013e3181cd35e0","article-title":"Immunohistochemical study of HER2 and TUBB3 proteins in extramammary Paget disease","volume":"32","author":"Miyamoto","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ejca.2026.117049_bib110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2559.2003.01648.x","article-title":"HER2 oncogene amplification in extramammary Paget\u2019s disease","volume":"42","author":"Tanskanen","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2026.117049_bib111","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf235","article-title":"Clinical and molecular landscape of metastatic extramammary Paget\u2019s disease","author":"Watanabe","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2026.117049_bib112","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/bjd\/ljae337","article-title":"Association of genetic alterations with prognosis in extramammary Paget disease: insights into the involvement of somatic CDKN2A variants in patients with a poor prognosis","volume":"192","author":"Iwasawa","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib113","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1111\/1346-8138.16898","article-title":"Treatment of high tumor mutation burden metastatic extramammary Paget disease with an anti\u2013PD-1 antibody","volume":"50","author":"Nakayama","year":"2023","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib114","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/exd.14476","article-title":"Genomic landscape of circulating tumour DNA in metastatic extramammary Paget\u2019s disease","volume":"31","author":"Sawamura","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ejca.2026.117049_bib115","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1158\/1078-0432.CCR-20-3205","article-title":"Unbiased Detection of Driver Mutations in Extramammary Paget Disease","volume":"27","author":"Ishida","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.117049_bib116","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jdermsci.2019.03.006","article-title":"Identification of genetic alterations in extramammary Paget disease using whole exome analysis","volume":"94","author":"Kiniwa","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ejca.2026.117049_bib117","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/cam4.2820","article-title":"Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget\u2019s disease","volume":"9","author":"Gatalica","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2026.117049_bib118","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10585-016-9804-z","article-title":"Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease","volume":"33","author":"Tanaka","year":"2016","journal-title":"Clin Exp Metastas--"},{"key":"10.1016\/j.ejca.2026.117049_bib119","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.ju.0000165148.16655.7c","article-title":"Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget\u2019s disease: a study of 31 patients","volume":"174","author":"Choi","year":"2005","journal-title":"J Urol"},{"issue":"25","key":"10.1016\/j.ejca.2026.117049_bib120","article-title":"Integrative genomic and transcriptomic profiling reveals dysregulation of FOXA1-AGR2 axis in penoscrotal extramammary Paget\u2019s disease","volume":"S0923-1811","author":"Zhang","year":"2025","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ejca.2026.117049_bib121","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.18632\/oncotarget.27272","article-title":"Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget\u2019s disease","volume":"10","author":"Nordmann","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2026.117049_bib122","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.2147\/OTT.S244814","article-title":"Response to Pyrotinib in a Chinese Patient with Bone-Metastatic Scrotal Paget\u2019s Disease Harboring Triple Uncommon HER2 Mutation: A Case Report","volume":"13","author":"Guo","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ejca.2026.117049_bib123","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1634\/theoncologist.2014-0054","article-title":"Treatment of Metastatic Extramammary Paget\u2019s Disease Associated With Adnexal Adenocarcinoma, With Anti-HER2 Drugs Based on Genomic Alteration ERBB2 S310F","volume":"19","author":"Vornicova","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2026.117049_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217146","article-title":"ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance","volume":"599","author":"Chen","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2026.117049_bib125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/acr-24-170","article-title":"PIK3CA inhibitor treatment for metastatic scrotal extramammary Paget\u2019s disease: a case report and literature review","volume":"9","author":"Huang","year":"2025","journal-title":"AME Case Rep"},{"key":"10.1016\/j.ejca.2026.117049_bib126","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/cancers12040820","article-title":"Frequent FOXA1-Activating Mutations in Extramammary Paget\u2019s Disease","volume":"12","author":"Takeichi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2026.117049_bib127","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ijc.27738","article-title":"Oncogenic mutations in extramammary Paget\u2019s disease and their clinical relevance","volume":"132","author":"Kang","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.117049_bib128","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/emboj.2011.340","article-title":"FOXA1: master of steroid receptor function in cancer","volume":"30","author":"Augello","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2026.117049_bib129","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s12885-023-10964-6","article-title":"AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer","volume":"23","author":"Zhou","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.117049_bib130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cup.70088","article-title":"Sweat Gland Carcinoma With Neuroendocrine Differentiation (SCAND) Harboring a Novel GATA3 Frameshift Extension Mutation: A Case Study With Protein Structural Modeling","volume":"53","author":"McCrary","year":"2026","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib131","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/PAS.0000000000002195","article-title":"Recurrent GATA3 P409Afs*99 Frameshift Extension Mutations in Sweat-gland Carcinoma With Neuroendocrine Differentiation","volume":"48","author":"Goto","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib132","first-page":"E6","article-title":"BF. Endocrine Mucin-Producing Sweat Gland Carcinoma and Primary Cutaneous Mucinous Carcinoma: A Case Series","volume":"112","author":"Barlow","year":"2023","journal-title":"Cutis"},{"key":"10.1016\/j.ejca.2026.117049_bib133","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/PAS.0000000000001462","article-title":"An Update on Endocrine Mucin-producing Sweat Gland Carcinoma: Clinicopathologic Study of 63 Cases and Comparative Analysis","volume":"44","author":"Agni","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2026.117049_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115750","article-title":"Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients","volume":"228","author":"Ugurel","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.117049_bib135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s10038-019-0658-5","article-title":"A new era of long-read sequencing for cancer genomics","volume":"65","author":"Sakamoto","year":"2020","journal-title":"J Hum Genet"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926008300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926008300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:34:13Z","timestamp":1790800453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926008300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":135,"alternative-id":["S0959804926008300"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117049","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic landscape of sweat gland carcinomas: Clinical applications and future directions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117049"}}